USE OF HYDROGENATED PYRIDO[4,3-B] INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS
摘要
<p>Methods of treating or suppressing oxidative stress diseases including mitochondrial diseases, impaired energy processing disorders, and diseases of aging such as diabetes and cancer with hydrogenated pyrido[4,3-b]indoles such as dimebolin, are disclosed.</p>
申请公布号
WO2010014758(A1)
申请公布日期
2010.02.04
申请号
WO2009US52163
申请日期
2009.07.29
申请人
EDISON PHARMACEUTICALS, INC.;MILLER, GUY, M.;WESSON, KIERON, E.
